Remove category the-obesity-revolution
article thumbnail

STAT+: Pharmalittle: Type 1 diabetes drug is priced at $194,000; abortion opponents sue FDA over abortion pill approval

STAT

And so, we leave you with this … Analysts forecast obesity medication is the next blockbuster pharmaceutical category, equivalent to the revolution in treating high blood pressure in the 1980s , The Financial Times tells us. Good morning, everyone, and welcome to another working week.

FDA 92